» Articles » PMID: 19136036

Effects of Adrenomedullin on Systolic and Diastolic Myocardial Function

Overview
Journal Peptides
Specialty Biochemistry
Date 2009 Jan 13
PMID 19136036
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Adrenomedullin (AM) effects were studied in rabbit papillary muscles by adding increasing concentrations (10(-10) to 10(-6)M) either alone or after pre-treatment with l-NNA, indomethacin, AM22-52 (AM receptor antagonist), CGRP(8-37) (CGRP receptors antagonist), KT5720 (PKA inhibitor), as well as after endocardial endothelium (EE) removal. Passive length-tension relations were constructed before and after a single concentration of AM (10(-6)M). AM concentration-dependently induced negative inotropic and lusitropic effects, and increased resting muscle length (RL). At 10(-6)M, AT, dT/dt(max) and dT/dt(min) decreased 20.9+/-4.9%, 18.3+/-7.3% and 16.7+/-7.8%, respectively, and RL increased to 1.010+/-0.004L/L(max). Correcting RL to its initial value resulted in a 26.6+/-6.4% decrease of resting tension, indicating decreased muscle stiffness, also patent in the down and rightward shift of the passive length-tension relation. The negative inotropic effect of AM was dependent on its receptor, CGRP receptor, PKA, the EE and NO, while the effects of AM on myocardial stiffness were abolished by EE damage and NO inhibition. This latter effect represents a novel mechanism of acute neurohumoral modulation of diastolic function, suggesting that AM is an important regulator of cardiac filling.

Citing Articles

Protein Kinase A as a Promising Target for Heart Failure Drug Development.

Saad N, Elnakish M, Ahmed A, Janssen P Arch Med Res. 2019; 49(8):530-537.

PMID: 30642654 PMC: 6451668. DOI: 10.1016/j.arcmed.2018.12.008.


Assessment of PKA and PKC inhibitors on force and kinetics of non-failing and failing human myocardium.

Saad N, Elnakish M, Brundage E, Biesiadecki B, Kilic A, Ahmed A Life Sci. 2018; 215:119-127.

PMID: 30399377 PMC: 6279240. DOI: 10.1016/j.lfs.2018.10.065.


Protein Kinases as Drug Development Targets for Heart Disease Therapy.

Dhalla N, Muller A Pharmaceuticals (Basel). 2016; 3(7):2111-2145.

PMID: 27713345 PMC: 4036665. DOI: 10.3390/ph3072111.


Effect of nucleoprotein factor-kB (NF-κB) in endothelial cells during high blood flow-associated pulmonary vascular remodeling on vasoactive substances adrenomedullin and prostacyclin.

Yang J, Wang W, Dong M, Yu X, Luo Q Int J Clin Exp Med. 2015; 8(8):13842-7.

PMID: 26550335 PMC: 4613020.


Reverse myocardial effects of intermedin in pressure-overloaded hearts: role of endothelial nitric oxide synthase activity.

Pires A, Pinho M, Alves B, Pinho S, Sena C, Seica R J Physiol. 2012; 591(3):677-87.

PMID: 23165766 PMC: 3577549. DOI: 10.1113/jphysiol.2012.240812.